Učitavanje...

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

The GAUDI study assessed safety and preliminary efficacy of induction therapy with obinutuzumab plus chemotherapy, followed by maintenance therapy with obinutuzumab alone, in previously untreated patients with follicular lymphoma. Assignment to chemotherapy was decided on a per-center basis before t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Haematologica
Glavni autori: Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395117/
https://ncbi.nlm.nih.gov/pubmed/28011903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.152272
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!